Jialei Fu
Overview
Explore the profile of Jialei Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
105
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Z, Cao B, Du J, Deng T, Wang R, Chen Y, et al.
BMC Plant Biol
. 2025 Mar;
25(1):332.
PMID: 40087613
Isatidis Folium, derived from the dried leaves of Isatis indigotica Fort., has been used for centuries as a traditional Chinese herb with antibacterial and antiviral properties. However, heterogeneity in cultivation...
2.
Wang C, Wang P, Fu J, Yang Z, Du H, Zhang M, et al.
Int J Biol Macromol
. 2024 Nov;
283(Pt 3):137713.
PMID: 39551317
The inflammatory response is the core of the pathogenesis of lipopolysaccharide (LPS)-induced sepsis myocardial injury (SMI). Pinus massoniana pollen polysaccharide (PPPS) is a natural polymer with known biological activities, including...
3.
Lao Y, Fu J, Chen Y, Xu B, Zhang S, Sheng H, et al.
Medicine (Baltimore)
. 2024 Nov;
103(45):e40392.
PMID: 39533591
Background: This prospective randomized controlled trial was designed to evaluate the clinical efficacy and safety of Bu Shen Tong Luo herbal compound as a complementary treatment for nonspecific low back...
4.
Fu J, Shin S
Clin Nutr
. 2024 Oct;
43(12):109-115.
PMID: 39442391
Background & Aims: We aimed to examine the association of lifestyle trajectory and total lifestyle change score with the risk of metabolic syndrome (MetS). Methods: We analyzed 2048 participants aged...
5.
Liu J, Fu J, Fu P, Liu M, Liu Z, Song B
Cancer Cell Int
. 2024 Jun;
24(1):224.
PMID: 38943199
Background: Despite effective strategies, resistance in EGFR mutated lung cancer remains a challenge. Metabolic reprogramming is one of the main mechanisms of tumor drug resistance. A class of drugs known...
6.
Jiang T, Tian J, Lei P, Meng C, Fu J, Cao L, et al.
Radiat Oncol
. 2024 May;
19(1):64.
PMID: 38807176
Purpose: This study aims to investigate the effects of chest wall bolus in intensity-modulated radiotherapy (IMRT) technology on clinical outcomes for post-mastectomy breast cancer patients. Materials And Methods: This retrospective...
7.
Lei P, Cao L, Zhang H, Fu J, Wei X, Zhou F, et al.
Transl Oncol
. 2024 Feb;
43:101911.
PMID: 38377934
Oxaliplatin (OXA)-based chemotherapy is one of the first-line treatments for advanced gastric cancer. However, the potential risk for chemotherapy-induced hepatic injury can hinder its effectiveness. Polyene phosphatidylcholine (PPC) is often...
8.
Yang M, Zhang Z, Fu J, Liu J, Pang J, Fan H, et al.
Heliyon
. 2023 Jul;
9(7):e18055.
PMID: 37519692
Background: Traditional Chinese medicine (TCM) has been used to prevent and treat type 2 diabetes (T2DM) for thousands of years. The holistic view of TCM and the "multitarget" characteristics of...
9.
Fu J, Shin S
Epidemiol Health
. 2023 Jun;
45:e2023037.
PMID: 37311642
Objectives: This study assessed the association of dietary patterns with the incidence of chronic kidney disease (CKD) and kidney function decline among Korean adults. Methods: Data were collected from the...
10.
Han S, Tian Z, Tian H, Han H, Zhao J, Jiao Y, et al.
Cell Death Discov
. 2023 Jun;
9(1):181.
PMID: 37301856
Hepatoma-derived growth factor (HDGF) expression is associated with poor prognosis in non-small cell lung cancer (NSCLC); however, whether HDGF affects gefitinib resistance in NSCLC remains unknown. This study aimed to...